Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer

Comparison of outcome after stereotactic ablative radiotherapy of patients with metachronous lung versus primary lung cancer

Abstract Background Early-stage lung cancer, primarily treated with surgery, often occur in poor surgical candidates (impaired respiratory function, prior thoracic surgery, severe comorbidities). Stereotactic ablative radiotherapy (SABR) is a non-invasive alternative that provides comparable local c...

Full description

Bibliographic Details
Main Authors: Jonathan Benzaquen, Pierre-Yves Bondiau, Josiane Otto, Charles-Hugo Marquette, Jean-Philippe Berthet, Arash O. Naghavi, Renaud Schiappa, Jean-Michel Hannoun-Levi, Bernard Padovani, Jérôme Doyen
Format: Article
Language:English
Published: BMC 2023-06-01
Series:Radiation Oncology
Subjects:
Second lung cancer
Metachronous tumors
Stereotactic ablative radiotherapy
Online Access:https://doi.org/10.1186/s13014-023-02286-5

Internet

https://doi.org/10.1186/s13014-023-02286-5

Similar Items